Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ vs Amlodipine in Hypertension with T2D and Albuminuria
NCT00171561Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan and hydrochlorothiazide in hypertension (HTN) and albuminuria (2 arms), sponsored by Novartis. Primary endpoint: Blood measures of hypertension at 24 weeks. Started Mar 2003; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)albuminuria
Beyond the preview
Go deeper on NCT00171561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171561.